Licence Changes & Product Updates

Branded generic of Fostair 100/6 pMDI launched for asthma and COPD

Branded generic of Fostair 100/6 pMDI launched for asthma and COPD

25 August 2021, 3:27pm

Luforbec 100/6 pressurised metered dose inhaler (pMDI)...

New warning for AstraZeneca COVID-19 vaccine

New warning for AstraZeneca COVID-19 vaccine

24 August 2021, 8:33am

A warning about Guillain-Barré syndrome has been added...

Moderna COVID-19 vaccine approved in adolescents

Moderna COVID-19 vaccine approved in adolescents

18 August 2021, 10:41am

The Moderna COVID-19 vaccine, now known as Spikevax,...

Irbesartan batches recalled over contamination

Irbesartan batches recalled over contamination

16 August 2021, 12:35pm

Batches of some irbesartan-containing products are...

Second SGLT2 inhibitor approved for heart failure

Second SGLT2 inhibitor approved for heart failure

11 August 2021, 3:57pm

Clinicians now have a choice of SGLT2 inhibitors to...

SGLT2 inhibitor licensed to treat chronic kidney disease

SGLT2 inhibitor licensed to treat chronic kidney disease

9 August 2021, 4:02pm

Forxiga (dapagliflozin) can now be prescribed to treat...

New contraindication for AstraZeneca COVID-19 vaccine

New contraindication for AstraZeneca COVID-19 vaccine

19 July 2021, 5:22pm

The AstraZeneca COVID-19 vaccine, now known as Vaxzevria,...

Chloramphenicol eye drops safe for under 2s, says MHRA

Chloramphenicol eye drops safe for under 2s, says MHRA

9 July 2021, 4:43pm

The balance between the benefits and risks of chloramphenicol...

Myocarditis warning for Pfizer and Moderna COVID-19 vaccines

Myocarditis warning for Pfizer and Moderna COVID-19 vaccines

28 June 2021, 4:26pm

Prescribing information for the Pfizer/BioNTech and...

MIMS drug shortages tracker updated with latest supply issues

MIMS drug shortages tracker updated with latest supply issues

14 June 2021, 5:26pm

Supply issues have been reported in the past week for...